Literature DB >> 16384673

Synthesis, characterization and stability of dendrimer prodrugs.

Mohammad Najlah1, Sally Freeman, David Attwood, Antony D'Emanuele.   

Abstract

The design, synthesis and characterization of a series of zero generation (G0) PAMAM dendrimer-based prodrugs for the potential enhancement of drug solubility and bioavailability are described. Naproxen, a poorly water-soluble drug, was conjugated to dendrimers either directly by an amide bond or by ester bonds using either L-lactic acid or diethylene glycol as a linker. All of the prodrugs were more hydrophilic than the parent drug, as evaluated by drug partitioning between 1-octanol and phosphate buffer (pH 7.4). Hydrolysis of the conjugates was measured at 37 degrees C in hydrochloric acid buffer (pH 1.2), phosphate buffer (pH 7.4), borate buffer (pH 8.5) and in 80% human plasma. The amide conjugate and both ester conjugates were chemically stable at all pHs over 48 h of incubation. Naproxen was enzymatically released from both ester conjugates in plasma; the lactic ester conjugate hydrolyzed slowly with only 25% of naproxen released after 24h, the diethylene glycol ester conjugate cleaved rapidly following pseudo first order kinetics (t(1/2) = 51 min). G0 PAMAM dendrimer prodrugs with an appropriate linker (diethylene glycol) show good potential as carriers for oral delivery.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16384673     DOI: 10.1016/j.ijpharm.2005.10.033

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  13 in total

Review 1.  Designing dendrimers for drug delivery and imaging: pharmacokinetic considerations.

Authors:  Wassana Wijagkanalan; Shigeru Kawakami; Mitsuru Hashida
Journal:  Pharm Res       Date:  2010-12-23       Impact factor: 4.200

2.  Design and exploratory data analysis of a second generation of dendrimer prodrugs potentially antichagasic and leishmanicide.

Authors:  Jeanine Giarolla; Kerly Fernanda Mesquita Pasqualoto; Elizabeth I Ferreira
Journal:  Mol Divers       Date:  2013-08-29       Impact factor: 2.943

3.  Dendrimer-drug conjugates for tailored intracellular drug release based on glutathione levels.

Authors:  Raghavendra S Navath; Yunus E Kurtoglu; Bing Wang; Sujatha Kannan; Robert Romero; Rangaramanujam M Kannan
Journal:  Bioconjug Chem       Date:  2008-12       Impact factor: 4.774

Review 4.  Transepithelial transport and toxicity of PAMAM dendrimers: implications for oral drug delivery.

Authors:  S Sadekar; H Ghandehari
Journal:  Adv Drug Deliv Rev       Date:  2011-09-29       Impact factor: 15.470

5.  Evaluation of poly(amidoamine) dendrimers as potential carriers of iminodiacetic derivatives using solubility studies and 2D-NOESY NMR spectroscopy.

Authors:  Magdalena Markowicz; Paweł Szymański; Marcin Ciszewski; Arkadiusz Kłys; Elżbieta Mikiciuk-Olasik
Journal:  J Biol Phys       Date:  2012-08-16       Impact factor: 1.365

6.  Dendrimer Conjugate of [4-(Tetradecanoylamino)benzyl]phosphonic Acid (S32826) as an Autotaxin Inhibitor.

Authors:  Natalie Fisher; Timothy Hilton-Bolt; Michael G Edwards; Katherine J Haxton; Michael McKenzie; Steven M Allin; Alan Richardson
Journal:  ACS Med Chem Lett       Date:  2013-11-18       Impact factor: 4.345

7.  Carboxyl-terminated PAMAM-SN38 conjugates: synthesis, characterization, and in vitro evaluation.

Authors:  Nirmalkumar Vijayalakshmi; Abhijit Ray; Alexander Malugin; Hamidreza Ghandehari
Journal:  Bioconjug Chem       Date:  2010-10-20       Impact factor: 4.774

8.  PAMAM-camptothecin conjugate inhibits proliferation and induces nuclear fragmentation in colorectal carcinoma cells.

Authors:  Giridhar Thiagarajan; Abhijit Ray; Alexander Malugin; Hamidreza Ghandehari
Journal:  Pharm Res       Date:  2010-06-15       Impact factor: 4.200

9.  Poly(amidoamine) dendrimer-drug conjugates with disulfide linkages for intracellular drug delivery.

Authors:  Yunus E Kurtoglu; Raghavendra S Navath; Bing Wang; Sujatha Kannan; Robert Romero; Rangaramanujam M Kannan
Journal:  Biomaterials       Date:  2009-01-25       Impact factor: 12.479

10.  Poly(ethylene glycol) (PEG)-lactic acid nanocarrier-based degradable hydrogels for restoring the vaginal microenvironment.

Authors:  Sujata Sundara Rajan; Yevgeniy Turovskiy; Yashveer Singh; Michael L Chikindas; Patrick J Sinko
Journal:  J Control Release       Date:  2014-09-16       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.